Multicenter Ozurdex® assessment for diabetic macular edema: MOZART study
Publié le 09 mai. 2014 par Sébastien Guigou
Purpose: To evaluate the efficiency and safety of intravitreal implant of 0.7mg dexamathasone in visual impairment due to diabetic macular edema (DME). Materials and methods: This was a retrospective, multicenter, study. Seventy-four patients, with a mean age of 65 years, followed for at least 6 months (mean follow-up: 9.8 months) were included in 5 French eye clinics (P 1.5 collective). The mean...

Vous devez être identifié pour accéder au contenu complet...

Partager

À voir également

Une étoile maculaire / PEVAC
Publié le 24 oct. 2023